The largest database of trusted experimental protocols

Transit x2

Manufactured by Mirus Bio
Sourced in United States, United Kingdom

The TransIT-X2 is a laboratory transfection reagent designed to facilitate the delivery of nucleic acids, such as plasmid DNA, mRNA, and siRNA, into a variety of cell types. The product is formulated to provide efficient and reliable transfection performance.

Automatically generated - may contain errors

200 protocols using transit x2

1

CRISPR Inhibitor Screening in HEK293T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293T cells were seeded at 2×104 cells/well in 96-well plates approximately 20 hours prior to transfection. Each transfection reaction consisted of 1.25 μL of TransIT-X2 (Mirus Bio) with 70 ng of nuclease, 30 ng of sgRNA/crRNA, and 110 ng of anti-CRISPR expression plasmids in a final volume of 20 μL otherwise containing Opti-MEM (Thermo Fisher Scientific). For control conditions containing no Acr plasmid, 110 ng of a pCMV-EGFP plasmid was utilized; for non-targeting sgRNA/crRNA conditions, 30 ng of an empty U6 promoter plasmid was used. For titration experiments, cells were transfected with 70 ng of nuclease, 30 ng sgRNA/crRNA, varying amounts of acr expression and DNA stuffer plasmids totaling 96.5 ng (0.5 ng Acr with 96 ng stuffer; 2.75 ng acr with 93.75 ng stuffer; 16 ng acr with 80.5 ng stuffer), and 1.17 μL of TransIT-X2 (Mirus Bio) in 20 μl Opti-MEM. DNA stuffer plasmids were an orthogonal and incompatible pCAG-MbCas12a expression plasmid. Genomic DNA was harvested approximately 72 hours post-transfection by suspending cells in 100 μL of lysis buffer (20 mM Hepes pH 7.5, 100 mM KCl, 5 mM MgCl2, 5% glycerol, 25 mM DTT, 0.1% Triton X-100, and 30 ng/μL Proteinase K (NEB)), followed by incubation at 65 °C for 6 minutes and 98 °C for 2 minutes. All experiments were performed with at least 3 independent biological replicates.
+ Open protocol
+ Expand
2

Modulation of CCR5 Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Hut-78 cell line was maintained in RPMI 1640 (Gibco) medium with 10% heat inactivated fetal bovine serum (FBS; Atlanta Biologicals). Hut-78 or primary CD4+ T cells from donors with rs1015164AG genotype were plated at a density of 0.5×106 cells/well in a 12 well plate and transfected with 100nM final concentration of either Control siRNA or gene-targeting (CCR5AS or Raly) siRNA optimized using TransIT-X2® (Mirus Bio LLC) protocol. The cells were incubated for 24 hours in a 37°C CO2 incubator before determining mRNA expression or the cell-surface expression of CCR5. Hut-78 cells were plated at a density of 0.5×106 cells/well and transfected with 1μg/well of the CCR5 3’UTR reporter constructs in the psichek2 vectors using the optimized TransIT-X2® (Mirus Bio LLC) protocol. Transfected Hut-78 cells were incubated for 24 hours at 37°C in a CO2 incubator. The cells were lysed, and Firefly and Renilla luciferase activity were measured using the Dual Luciferase Reporter Assay System (Promega). Renilla luciferase activity was normalized relative to Firefly luciferase activity for each transfection. All experiments were performed with six replicates in two independent experiments.
+ Open protocol
+ Expand
3

Establishing Prostate Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
The RWPE‐1 and C4‐2 cell lines were kindly provided by Dr. Hsing‐Jien Kung. The PC3, LNCaP, 22Rv1, and DU145 cell lines were obtained from the Bioresource Collection and Research Center (BCRC), Taiwan. RWPE‐1 was maintained in Keratinocyte Serum‐Free Medium (K‐SFM; Invitrogen) with 0.05 mg/ml bovine pituitary extract (BPE) and 5 ng/ml human recombinant epidermal growth factor (EGF) at 37°C in 5% CO2. LNCaP, C4‐2, 22Rv1, and DU145 were maintained in RPMI 1640 medium (RPMI; Invitrogen) with 10% FBS at 37°C in 5% CO2. PC3 cells were maintained in Dulbecco modified Eagle medium (DMEM; Invitrogen) with 10% FBS at 37°C in 5% CO2. Plasmids were transfected using TransIT 2020 or TransIT X2 (Mirus Bio), while short interfering RNA (siRNA) was transfected using Lipofectamine RNAiMAX (Invitrogen) or TransIT X2 (Mirus Bio). PC3 cell lines stably expressing control or CTH shRNA were selected using puromycin (Sigma‐Aldrich) and established as mass culture. DU145 cell lines stably expressing PCDNA or PCDNA‐CTH were selected using G418 (Sigma‐Aldrich) and established as mass culture.
+ Open protocol
+ Expand
4

CRISPR Inhibitor Screening in HEK293T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293T cells were seeded at 2×104 cells/well in 96-well plates approximately 20 hours prior to transfection. Each transfection reaction consisted of 1.25 μL of TransIT-X2 (Mirus Bio) with 70 ng of nuclease, 30 ng of sgRNA/crRNA, and 110 ng of anti-CRISPR expression plasmids in a final volume of 20 μL otherwise containing Opti-MEM (Thermo Fisher Scientific). For control conditions containing no Acr plasmid, 110 ng of a pCMV-EGFP plasmid was utilized; for non-targeting sgRNA/crRNA conditions, 30 ng of an empty U6 promoter plasmid was used. For titration experiments, cells were transfected with 70 ng of nuclease, 30 ng sgRNA/crRNA, varying amounts of acr expression and DNA stuffer plasmids totaling 96.5 ng (0.5 ng Acr with 96 ng stuffer; 2.75 ng acr with 93.75 ng stuffer; 16 ng acr with 80.5 ng stuffer), and 1.17 μL of TransIT-X2 (Mirus Bio) in 20 μl Opti-MEM. DNA stuffer plasmids were an orthogonal and incompatible pCAG-MbCas12a expression plasmid. Genomic DNA was harvested approximately 72 hours post-transfection by suspending cells in 100 μL of lysis buffer (20 mM Hepes pH 7.5, 100 mM KCl, 5 mM MgCl2, 5% glycerol, 25 mM DTT, 0.1% Triton X-100, and 30 ng/μL Proteinase K (NEB)), followed by incubation at 65 °C for 6 minutes and 98 °C for 2 minutes. All experiments were performed with at least 3 independent biological replicates.
+ Open protocol
+ Expand
5

DsiRNA Knockdown of ZAP and CSTF2 in Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Specific DsiRNAs against ZAP-S and ZAP-L were custom-designed and
obtained from Integrated DNA Technologies (IDT) (Supplementary Table 2). DsiRNA
against CSTF2 was obtained from IDT (hs.Ri.CSTF2.13.1). For
knockdown experiments, DsiRNA was transfected at 10–20 nM final
concentration using TransIT-X2 (Mirus Bio) according to the
manufacturer’s instructions. Stimulations of cells were performed
24–36 h after DsiRNA transfection. Co-transfections of DsiRNA and poly
U/UC RNA or expression plasmids were performed using TransIT-X2
(Mirus Bio) at a DsiRNA concentration of 10–20 nM. Cells were analyzed
24–42 h post transfection.
+ Open protocol
+ Expand
6

CRISPR Inhibition Assay in HEK293T

Check if the same lab product or an alternative is used in the 5 most similar protocols
Approximately 20 hours prior to transfection, HEK 293T cells were seeded at 2×104 cells/well in 96-well plates. Cells were transfected using 70 ng of nuclease, 30 ng sgRNA/crRNA, and 110 ng of acr expression plasmids with 1.25 μL of TransIT-X2 (Mirus Bio) in 20 μL Opti-MEM. For control conditions containing no acr plasmid, 110 ng of a pCMV-EGFP plasmid was utilized as filler DNA; for non-targeting sgRNA/crRNA conditions, 30 ng of an empty U6 promoter plasmid was used as filler DNA. For titration experiments cells were transfected using 70 ng of nuclease, 30 ng sgRNA/crRNA, varying amounts of acr expression and DNA stuffer plasmids totaling 197 ng (6 ng acr with 191 ng stuffer; 22 ng acr with 175 stuffer; 62 ng acr with 135 stuffer; 197 ng acr with no stuffer), and 1.77 μL of TransIT-X2 (Mirus Bio) in 20 μL Opti-MEM. DNA stuffer plasmids were an orthogonal and incompatible pCAG-nuclease expression plasmid. Genomic DNA was harvested from cells 72 hours post-transfection by suspending cells in 100 μL of lysis buffer (20 mM Hepes pH 7.5, 100 mM KCl, 5 mM MgCl2, 5% glycerol, 25 mM DTT, 0.1% Triton X-100, and 30 ng/uL Proteinase K (NEB)), followed by incubation at 65°C for 6 minutes and 98°C for 2 minutes. All experiments were performed with at least 3 independent biological replicates.
+ Open protocol
+ Expand
7

CRISPR-Cas9 Knockdown of Jmjd2b in Trophoblast Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
TSCs were transfected with 62.5 nM double-stranded siRNA (GenePharma, China) using TransIT-X2 (Mirus Bio, WI, USA) according to the manufacturer’s instructions. Samples were analyzed 72 h after transfection. For CRISPR-Cas9 genome editing, TSCs were transduced by lentivirus generated from the LentiCRISPRv2-mCherry plasmid. The mCherry positive Cas9-expressing TSCs were isolated by fluorescence activated cell sorting (FACS) using BD FACSAria II cell sorter (BD Bioscience, CA USA). Two Alt-R CRISPR-Cas9 crRNAs (IDT, IA, USA), which targeted the Jmjd2b genomic sequence, were synthesized and separately annealed with the Alt-R CRISPR-Cas9 tracrRNA (IDT) to form the duplexed oligo. The Cas9-expressing TSCs were transfected with 90 nM duplexed oligo using TransIT-X2 (Mirus Bio). Two Jmjd2b-knockdown TSC lines were selected and verified by T7 endonuclease I digestion and Sanger sequencing (Supplementary Fig. 9). The Jmjd2b-knockdown TSCs were used for other experiments within 5 passages. The siRNA and crRNA sequences were listed in Supplementary Table 4.
+ Open protocol
+ Expand
8

Modulation of CCR5 Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Hut-78 cell line was maintained in RPMI 1640 (Gibco) medium with 10% heat inactivated fetal bovine serum (FBS; Atlanta Biologicals). Hut-78 or primary CD4+ T cells from donors with rs1015164AG genotype were plated at a density of 0.5×106 cells/well in a 12 well plate and transfected with 100nM final concentration of either Control siRNA or gene-targeting (CCR5AS or Raly) siRNA optimized using TransIT-X2® (Mirus Bio LLC) protocol. The cells were incubated for 24 hours in a 37°C CO2 incubator before determining mRNA expression or the cell-surface expression of CCR5. Hut-78 cells were plated at a density of 0.5×106 cells/well and transfected with 1μg/well of the CCR5 3’UTR reporter constructs in the psichek2 vectors using the optimized TransIT-X2® (Mirus Bio LLC) protocol. Transfected Hut-78 cells were incubated for 24 hours at 37°C in a CO2 incubator. The cells were lysed, and Firefly and Renilla luciferase activity were measured using the Dual Luciferase Reporter Assay System (Promega). Renilla luciferase activity was normalized relative to Firefly luciferase activity for each transfection. All experiments were performed with six replicates in two independent experiments.
+ Open protocol
+ Expand
9

Lipid and Polymer Complexation for Nucleic Acid Delivery

Check if the same lab product or an alternative is used in the 5 most similar protocols
Complexes were always freshly prepared using non-supplemented Opti-MEM (Life Technologies, Carlsbad, CA) by mixing selected lipid vectors (Lipofectamine 3000, Invitrogen, Waltham, MA) or 3DFect (OzBiosciences, Marseille, France) with respective nucleic acids (pDNA or cmRNA). The nucleic acid to vector ratio was 1:2, and the volume to weight ratios were followed as described in the instructions provided by the vector manufacturers. Similarly, polymer-based complexes were prepared by mixing TransIT-X2 (Mirus Bio, Madison, WI) with either pDNA or cmRNA in non-supplemented Opti-MEM with a nucleic acid to vector ratio of 1:3. The nucleic acid-vector mixtures were incubated for 20 min at room temperature to allow complex assembling and formation.
+ Open protocol
+ Expand
10

Exploring HSP27 Knockdown and Rescue in HUVECs and HDMECs

Check if the same lab product or an alternative is used in the 5 most similar protocols
HUVECs and HDMECs were transfected with siRNAs using TransIT-X2 (Mirus Bio) according to the manufacturer’s instructions. HSPB1-specific (HSP27) siRNA (5’-AAGGACGAGCATGGCTACATC-3’) was used at 12.5 nM in HUVECs and at 25 nM in HDMECs; MAPKAPK2-specific (MK2) siRNA (5’-CTACGAGCAGATCAAGATAAA-3’) was used at 25 nM; MAPKAPK3-specific (MK3) siRNA (5’-CCAGATAGTAATAAACACCAT-3’) was used at 25 nM; MAPK14-specific (p38α) siRNA (5’-AACTGCGGTTACTTAAACATA-3’) was used at 25 nM. All siRNAs, including nonspecific All Stars Negative Control siRNA (5’-GGCUACGUCCAGGAGCGCACC-3’), were purchased from Qiagen. HSP27 siRNA knockdown-rescue experiments were performed by transfecting HDMECs with HSP27-specific siRNA or nonspecific siRNA control for 5 days. The siRNA-resistant HSP27 wildtype and TriA mutant cDNA plasmids (0.2 μg) were introduced into HDMECs by electroporation and barrier impedance was determined after 36 hours.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!